FREQUENTLY ASKED QUESTIONS
Souvenaid® is a medical nutrition drink that nutritionally supports memory function in the early stages of Alzheimer’s disease. Taken once daily for 6 months, Souvenaid has been shown to benefit people during the early stages. What makes Souvenaid® so unique is its patented formula known as Fortasyn™ Connect, a combination of nutrients which provide the nutritional building blocks to support growth of brain connections. It takes time for these nutrients to be taken up and used by the body, so there is no noticeable effect straight away. Therefore, it is important to keep taking Souvenaid® every day to ensure a continuous and adequate supply of important nutrients for the brain.
Souvenaid® is for people who are in the early stages of Alzheimer’s disease. The clinical benefit of Souvenaid® has so far only been demonstrated in people during the early stages of Alzheimer’s disease. Souvenaid® must be used under medical supervision.
Souvenaid® contains a unique and patented combination of nutrients (known as Fortasyn Connect™) at levels difficult to achieve from normal dietary intake alone. This combination of nutrients in Souvenaid® is designed to support memory function in people living with early Alzheimer’s disease and includes fish oil, phospholipids, choline, uridine monophosphate, vitamin E, vitamin C, vitamin B12, vitamin B6 and folic acid. LEARN MORE
There is a growing body of evidence showing that people with memory loss in early Alzheimer’s disease often have low levels of some key nutrients (omega-3 fatty acids, uridine monophosphate, phospholipids, b-vitamins and choline), despite eating a normal diet. Souvenaid® has been designed to provide these essential nutrients that are required for synapse formation.
Souvenaid® provides the nutrients required, in addition to a person’s normal daily dietary intake, to support synapse formation which in turn is associated with memory function. Therefore, Souvenaid® nutritionally supports memory function in people during the early stages of Alzheimer’s disease.
Souvenaid® is a single serve drink making it easy and convenient for people to take. It can be consumed straight from the bottle, through a straw or from a glass. It comes in three flavours; vanilla, strawberry and cappuccino. It tastes best served chilled, so we recommend keeping a few bottles in the fridge. Alternatively if you want to turn your daily Souvenaid® into a delicious creation, check out our great range of recipes.
Clinical studies have demonstrated that Souvenaid® can be used safely alongside commonly prescribed Alzheimer’s disease medication.
Souvenaid® comes in three flavours; vanilla, cappuccino and strawberry. It tastes best served chilled, so we recommend keeping a few bottles in the fridge. To taste all 3 flavour, request your free sample pack today.
In order to benefit from taking Souvenaid®, it is recommended that one 125mL bottle of Souvenaid® should be consumed once a day for a minimum of 6 months. The length of use of Souvenaid® by an individual should be determined by their recommending healthcare professional.
Souvenaid® is indicated for the dietary management of people with early Alzheimer’s disease. Souvenaid® has not been tested in people who do not have Alzheimer’s disease. You should consult your health care professional about whether it is appropriate to take Souvenaid®.
Souvenaid® is not intended to prevent the disease nor is it a treatment and it should only be used by people who have already been diagnosed with early Alzheimer’s disease. It must be used under medical supervision.
Souvenaid® is a medical nutrition drink clinically proven to be beneficial in the dietary management of people with early Alzheimer’s disease. Clinical trials of Souvenaid® in combination with coconut oil or food supplements have not been carried out.
This question is best answered by your healthcare professional. Clinical trials directly comparing Souvenaid® with fish oil and vitamin supplements have not been carried out.
Souvenaid® contains a unique combination of nutrients at levels difficult to achieve from diet alone. In early Alzheimer’s disease, dietary intake of nutrients may be affected by worsening of appetite, taste and smell, which lead to reduced food consumption, food neglect and changes in food preferences.
In addition, research suggests that people with early Alzheimer’s disease have higher requirements than people without the disease for certain nutrients supporting brain function. It would be extremely difficult to modify your diet to achieve the right combination of specific nutrients and unreasonable to expect people to eat enough of the right foods.
Souvenaid® is not suitable for patients with galactosaemia. Galactosaemia is a genetic disease where a person cannot metabolise galactose.
Souvenaid® is not suitable as a sole source of nutrition and should be used in addition to normal dietary intake.
- People who have an allergy to milk protein, fish oil or soy may not be able to consume Souvenaid®.
- Souvenaid® is not suitable for people with galactosaemia.
- Souvenaid® is free from gluten-containing ingredients (<20mg/kg).
- Souvenaid® is low lactose (<300mg/kg).
- People with diabetes can consume Souvenaid®. However, Souvenaid® does contain carbohydrates and, as with other foods containing carbohydrate, it is advisable for people with diabetes to monitor their blood glucose levels in consultation with their diabetes medical team.
To see if this product is right for you, please speak to your healthcare professional. Alternatively if you have specific questions about the product, please call our customer care team on 0800 438 500.